Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity
(2015)
Journal Article
Neuroblastoma is the most common extra cranial solid tumour of childhood, and survival remains poor for patients with advanced disease. Novel immune therapies are currently in development, but clinical outcomes have not matched preclinical results. H... Read More about Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity.